Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-09-03

FDA Approved: PROCHLORPERAZINE — Supplemental Application (Cosette Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Cosette Pharmaceuticals, Inc.'s supplemental application for Prochlorperazine, a generic antiemetic, under ANDA 040058.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • prochlorperazine (prochlorperazine)

Snippet

SUPPL AP for PROCHLORPERAZINE (PROCHLORPERAZINE)